Trial Profile
Efficacy and safety of ustekinumab in the treatment of oral ulcers (OU) in patients with Behcet's Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Behcet's syndrome; Oral ulcer
- Focus Therapeutic Use
- 25 Apr 2018 New trial record